ArticleBritish journal of cancer2016
Randomised, open-label, phase II study of gemcitabine with and without IMM-101 for advanced pancreatic cancer.
Article in British journal of cancer, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04137822 (Expanded Access Program Using IMM-101 for Patients With Advanced Pancreatic Cancer), which is not on this map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Expanded Access Program Using IMM-101 for Patients With Advanced Pancreatic Cancer
Who cites it
8 citing papers in PubMed.
- Article
- Anti-Tumor Effect of Heat-KilledInternational journal of molecular sciences · 2022Article
- Long-term benefit from immune modulation and anti-inflammatory treatment in metastatic mesothelioma.Respiratory medicine case reports · 2020Article
- Biovacc-19: A Candidate Vaccine for Covid-19 (SARS-CoV-2) Developed from Analysis of its General Method of Action for Infectivity.QRB discovery · 2020Article
- Article
- Enhanced effect of checkpoint inhibitors when given after or together with IMM-101: significant responses in four advanced melanoma patients with no additional major toxicity.Journal of translational medicine · 2018Article
- Novel agents for pancreatic ductal adenocarcinoma: emerging therapeutics and future directions.Journal of hematology & oncology · 2018Review
- Role of modern immunotherapy in gastrointestinal malignancies: a review of current clinical progress.Journal of hematology & oncology · 2017Review
Corrections and comments
- Erratum for
Authors and funding
23 authors.
Funding
Abstract
PubMed holds no abstract for this paper.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.